[Federal Register Volume 85, Number 68 (Wednesday, April 8, 2020)]
[Notices]
[Page 19766]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07414]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Secretary; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Muscular Dystrophy 
Coordinating Committee (MDCC).
    The meeting will be open to the public. Individuals who plan to 
participate and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should notify the 
Contact Person listed below in advance of the meeting.

    Name of Committee: Muscular Dystrophy Coordinating Committee.
    Date: June 8, 2020.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: The purpose of this meeting is to bring together 
committee members, representing government agencies, patient 
advocacy groups, other voluntary health organizations, and patients 
and their families to update one another on progress relevant to the 
Action Plan for the Muscular Dystrophies and to coordinate 
activities and discuss gaps and opportunities leading to better 
understanding of the muscular dystrophies, advances in treatments, 
and improvements in patients' and their families' lives. Prior to 
the meeting, an agenda will be posted to the MDCC meeting 
registration website: https://meetings.ninds.nih.gov/meetings/MDCC2020.
    Registration: To register, please go to: https://meetings.ninds.nih.gov/Home/Registration/26698.
    Webcast Live: https://nih.webex.com/nih/onstage/g.php?MTID=e1c2d0bed65aa419911386eaa2ea2bb42.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Blvd., Bethesda, MD 20892 (Video Assisted Meeting).
    Contact Person: Glen Nuckolls, Ph.D., Program Director, NINDS/
NIH, Neuroscience Center, 6001 Executive Blvd., Rm 2203, Bethesda, 
MD 20892, 301-496-5876, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    More information can be found on the Muscular Dystrophy 
Coordinating Committee home page: https://mdcc.nih.gov/.

    Dated: April 2, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-07414 Filed 4-7-20; 8:45 am]
 BILLING CODE 4140-01-P